Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
Go back to Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition| eLandia International, Inc. (NYSE: ELAN) | Delayed: 22.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.43 | 52 Week High | $0.65 | |||
| Open | $22.43 | 52 Week Low | $0.03 | |||
| Day High | $22.43 | P/E | N/A | |||
| Day Low | $22.43 | EPS | $-0.60 | |||
| Volume | 9 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1164.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1164.89 | 52 Week High | $88.16 | |||
| Open | $1164.89 | 52 Week Low | $67.88 | |||
| Day High | $1164.89 | P/E | 269.65 | |||
| Day Low | $1164.89 | EPS | $4.32 | |||
| Volume | 28,947 | |||||
